Quantcast

Latest dyslipidemia Stories

2015-05-22 08:26:46

First Positive Regulatory Agency Determination for a PCSK9 Inhibitor THOUSAND OAKS, Calif., May 22, 2015 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that the Committee for Medicinal

2015-03-20 08:28:12

Submission of Application in Japan Marks an Important Milestone in Strategic Partnership With Amgen Astellas BioPharma THOUSAND OAKS, Calif., March 20, 2015 /PRNewswire/ -- Amgen (NASDAQ: AMGN)

2015-03-14 12:20:37

Data From PCSK9 Inhibitor Study Support Regulatory Filing in Japan THOUSAND OAKS, Calif., March 14, 2015 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced new detailed data from the Phase

2015-02-10 23:13:55

The 19th Annual CME Conference on Hypertension, Diabetes and Dyslipidemia is scheduled for June 26-28 in Charleston, SC by the Continuing Education Company Inc.

2015-02-09 23:06:48

The agenda for the 19th Annual Conference on Hypertension, Diabetes and Dyslipidemia has been released.

2015-01-27 23:03:27

RnRMarketResearch.com adds “Dyslipidemia – Pipeline Review, H1 2015” to its store.

2014-11-18 16:26:22

Additional Data Analysis Showed Every Two Week and Monthly Dosing Regimens of Evolocumab Were Clinically Equivalent THOUSAND OAKS, Calif., Nov.

2014-11-10 08:34:30

THOUSAND OAKS, Calif., Nov. 10, 2014 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that the U.S.

2014-10-21 08:32:43

DALLAS, October 21, 2014 /PRNewswire/ -- RnRMarketResearch.com adds EpiCast Report: Dyslipidemia - Epidemiology Forecast to 2023 market research of 94 pages to the Therapeutics

2014-10-01 20:24:10

Data From Phase 3 RUTHERFORD-2 Study Show Evolocumab Significantly Reduced Mean LDL-C by 59-66 Percent Compared to Placebo in Patients With Heterozygous Familial Hypercholesterolemia


Word of the Day
overword
  • To say in too many words; to express verbosely.
  • To express in too many words: sometimes used reflexively.
  • The leading idea or a repeated phrase, as of a song or ballad; the refrain; burden.
The word 'overword' comes from over- +‎ word.